Imerslund-Grasbeck syndrome: Difference between revisions

	WikiDoc Resources for Imerslund-Grasbeck syndrome
Articles
Most recent articles on Imerslund-Grasbeck syndrome Most cited articles on Imerslund-Grasbeck syndrome Review articles on Imerslund-Grasbeck syndrome Articles on Imerslund-Grasbeck syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Imerslund-Grasbeck syndrome Images of Imerslund-Grasbeck syndrome Photos of Imerslund-Grasbeck syndrome Podcasts & MP3s on Imerslund-Grasbeck syndrome Videos on Imerslund-Grasbeck syndrome
Evidence Based Medicine
Cochrane Collaboration on Imerslund-Grasbeck syndrome Bandolier on Imerslund-Grasbeck syndrome TRIP on Imerslund-Grasbeck syndrome
Clinical Trials
Ongoing Trials on Imerslund-Grasbeck syndrome at Clinical Trials.gov Trial results on Imerslund-Grasbeck syndrome Clinical Trials on Imerslund-Grasbeck syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Imerslund-Grasbeck syndrome NICE Guidance on Imerslund-Grasbeck syndrome NHS PRODIGY Guidance FDA on Imerslund-Grasbeck syndrome CDC on Imerslund-Grasbeck syndrome
Books
Books on Imerslund-Grasbeck syndrome
News
Imerslund-Grasbeck syndrome in the news Be alerted to news on Imerslund-Grasbeck syndrome News trends on Imerslund-Grasbeck syndrome
Commentary
Blogs on Imerslund-Grasbeck syndrome
Definitions
Definitions of Imerslund-Grasbeck syndrome
Patient Resources / Community
Patient resources on Imerslund-Grasbeck syndrome Discussion groups on Imerslund-Grasbeck syndrome Patient Handouts on Imerslund-Grasbeck syndrome Directions to Hospitals Treating Imerslund-Grasbeck syndrome Risk calculators and risk factors for Imerslund-Grasbeck syndrome
Healthcare Provider Resources
Symptoms of Imerslund-Grasbeck syndrome Causes & Risk Factors for Imerslund-Grasbeck syndrome Diagnostic studies for Imerslund-Grasbeck syndrome Treatment of Imerslund-Grasbeck syndrome
Continuing Medical Education (CME)
CME Programs on Imerslund-Grasbeck syndrome
International
Imerslund-Grasbeck syndrome en Espanol Imerslund-Grasbeck syndrome en Francais
Business
Imerslund-Grasbeck syndrome in the Marketplace Patents on Imerslund-Grasbeck syndrome
Experimental / Informatics
List of terms related to Imerslund-Grasbeck syndrome

VisualWikitext

Revision as of 05:58, 8 July 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief Aditya Govindavarjhulla, M.B.B.S. [2]; Assistant Editor-in-Chief: Robert Shafton

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Imerslund-Grasbeck syndrome or Imerslund-Najman-Grasbeck syndrome or Imerslund-Grasbeck disease (IGS or INGS) is an autosomal recessive, familial form of vitamin B₁₂ deficiency caused by malfunction of the receptor located in the terminal ileum.

Signs and symptoms

Defined as those seen in any macrocytic, megaloblastic anemia:

Anemia
Glossitis
Cheilosis
Tabes dorsalis
Peripheral neuropathy
Pancytopenia
Methylmalonyl CoA-emia
hypersegmented neutrophils and large RBCs
Increased MCV (Mean Corpuscular Volume), decreased Hgb/Hct (indicating anemia), and decreased value of vitamin B₁₂
Proteinuria
Reversal of all symptoms except neurological symptoms, by IV injection of vitamin B₁₂.

Genetics

Autosomal recessive pattern of inheritance. The suspected chromosome is 14.

Treatment

Injection of IV vitamin B₁₂. Early administration is helpful in reversal of few symptoms.

References

Template:SIB Template:WH Template:WS

@@ Line 2: / Line 2: @@
 {{CMG}};
-'''Associate Editor-in-Chief''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]] [mailto:agovi@perfuse.org]; '''Assistant Editor-in-Chief:''' Robert Shafton
+'''Associate Editor-in-Chief''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]] [mailto:agovi@perfuse.org];
+'''Assistant Editor-in-Chief:''' Robert Shafton
 {{EJ}}
@@ Line 13: / Line 14: @@
 ==Signs and symptoms==
 Defined as those seen in any macrocytic, megaloblastic anemia:
-*[[Anemia]]: causing fatigue, conjuctival palor, pale complexion, and in some cases, a mild icterus (yellowing of the eye).
+*[[Anemia]]
-*[[Glossitis]]("shiny tongue"): shiny, glossy tongue.
+*[[Glossitis]]
-*[[Cheilosis]](stomatitis): Inflammation of the edges of the lips and the oral mucosa.
+*[[Cheilosis]]
-*[[Tabes dorsalis]] ("subacute combined degeneration of the spinal cord"): This involves the posterior section of the spinal cord and therefore involves [[proprioception]] (sense of position), touch, sense of vibration and in severe cases the [[lateral corticospinal tract]], causing spastic paralysis of the limbs.
+*[[Tabes dorsalis]]
-*Peripheral [[neuropathy]]: tingling sensation in the arms and legs.
+*Peripheral [[neuropathy]]
-*[[Pancytopenia]]: decreased number of blood cells, due to decreased bone marrow production.
+*[[Pancytopenia]]
-*[[Methylmalonyl CoA-emia]]: defined as blood having and unusually high concentration of [[methylmalonyl CoA]].
+*[[Methylmalonyl CoA-emia]]
-*Peripheral findings such as [[hypersegmented neutrophils]] and large RBCs on high field view of the blood smears.
+*[[hypersegmented neutrophils]] and large RBCs
-*Laboratory findings indicating increased [[MCV]] (Mean Corpuscular Volume), decreased [[Hgb]]/[[Hct]] (indicating anemia), and decreased value of vitamin B<sub>12</sub> in the blood.
+* Increased [[MCV]] (Mean Corpuscular Volume), decreased [[Hgb]]/[[Hct]] (indicating anemia), and decreased value of vitamin B<sub>12</sub>
-*Proteinuria: protein found in the urine detected by analysis or by [[dipstick]].
+*Proteinuria
 *Reversal of all symptoms except neurological symptoms, by IV injection of vitamin B<sub>12</sub>.
-*[[Schilling test]] indicating <u>no</u> radioactive vitamin B<sub>12</sub> in the urine. (This test has dropped out of favor and should not be tried in patients with any form of renal failure).
 ==Genetics==
-The disease is autosomal recessive, and can therefore skip generations. Mutations in either amnionless (AMN) or cubilin can be the culprit. The suspected chromosome is 14. Due to its autosomal recessive pattern of inheritance, affected individuals (persons possessing a [[homozygous]] [[recessive]] [[genotype]]) need to undergo genetic counselling to identify risk of family members who might be [[heterozygous]] [[genetic carrier]]s.
+Autosomal recessive pattern of inheritance. The suspected chromosome is 14.
 ==Treatment==
-Since the essential pathology is due to the inability to absorb vitamin B12 from the bowels, the solution is therefore injection of IV vitamin B12. Timing is essential, as some of the side effects of vitamin B12 deficiency are reversible (such as RBC indices, peripheral RBC smear findings such as hypersegmented neutrophils, or even high levels of methylmalonyl CoA), but some side effects are irreversible as they are of a neurological source (such as tabes dorsalis, and peripheral neuropathy). High suspicion should be exercised when a neonate, or a pediatric patient presents with anemia, proteinuria, sufficient vitamin B12 dietary intake, and no signs of [[pernicious anemia]].
+Injection of IV vitamin B<sub>12</sub>. Early administration is helpful in reversal of few symptoms.
 ==References==